---
title: "国泰海通维持对百济神州有限公司（6160）的买入评级"
description: "国泰君安重申了对百济神州（6160）的买入评级，设定目标价为 212.09 港元，而该股收盘价为 192.30 港元。分析师共识为强烈买入，平均目标价为 244.52 港元，显示出 27.16% 的潜在上涨空间。此外，星展银行也维持了买入评级，目标价更高，达到 290.00 港元"
type: "news"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/277311616.md"
published_at: "2026-02-28T14:26:53.000Z"
---

# 国泰海通维持对百济神州有限公司（6160）的买入评级

> 国泰君安重申了对百济神州（6160）的买入评级，设定目标价为 212.09 港元，而该股收盘价为 192.30 港元。分析师共识为强烈买入，平均目标价为 244.52 港元，显示出 27.16% 的潜在上涨空间。此外，星展银行也维持了买入评级，目标价更高，达到 290.00 港元

在昨天发布的一份报告中，国泰君安维持了对百济神州的买入评级，目标价为 212.09 港元。该公司的股票昨天收盘价为 192.30 港元。

### 享受 TipRanks 高级版 50% 折扣

-   解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策
-   通过最新的新闻和分析保持市场领先，最大化您的投资组合潜力

目前，分析师对百济神州的共识评级为强烈买入，平均目标价为 244.52 港元，代表 27.16% 的上涨空间。在昨天发布的一份报告中，星展银行也维持了该股票的买入评级，目标价为 290.00 港元。

### Related Stocks

- [ONC.US - 百济神州](https://longbridge.com/zh-CN/quote/ONC.US.md)
- [06160.HK - 百济神州](https://longbridge.com/zh-CN/quote/06160.HK.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| BeOne Medicines posts 2025 results and issues cautious 2026 outlook | BeOne Medicines Ltd, a biopharmaceutical company based in Switzerland and listed in Hong Kong, has released its unaudite | [Link](https://longbridge.com/zh-CN/news/277035413.md) |
| Hong Kong-listed Chinese drug firms set to turn corner on rising sales, deals | Hong Kong-listed Chinese pharmaceutical companies are poised for profitability due to rising drug sales and lucrative li | [Link](https://longbridge.com/zh-CN/news/277340041.md) |
| Guotai Haitong Remains a Buy on Zai Lab Ltd (1ZLB) | Guotai Haitong analyst maintained a Buy rating on Zai Lab Ltd yesterday and set a price target of HK$27.94.Claim 50% Off | [Link](https://longbridge.com/zh-CN/news/277338249.md) |
| Nine Dragons Paper Holdings (NDGPF) Receives a Buy from GF Securities | GF Securities analyst maintained a Buy rating on Nine Dragons Paper Holdings yesterday and set a price target of HK$9.87 | [Link](https://longbridge.com/zh-CN/news/277339226.md) |
| CICC Reaffirms Their Buy Rating on JNBY Design (JNBYF) | CICC has reaffirmed a Buy rating on JNBY Design (JNBYF) with a price target of HK$24.97, while the shares closed at HK$2 | [Link](https://longbridge.com/zh-CN/news/277274710.md) |

---

> **免责声明**：本文内容仅供参考，不构成任何投资建议。